Company Pharmas Srl with Fiscal Code 2454666
recorded a turnover of 2024 of
36.525,
with a net profit of
12.230
and having an average number of employees of
- .
The company operates in the field of Închirierea şi subînchirierea bunurilor imobiliare proprii sau închiriate having the NACE code 6820.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Pharmas Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
11.928
14.432
21.890
22.575
22.608
10.367
18.464
26.532
26.538
36.525
Total Income - EUR
11.942
93.831
22.870
23.498
23.738
12.089
41.217
27.077
27.271
40.606
Total Expenses - EUR
16.609
46.240
16.939
17.446
16.123
7.604
20.379
25.836
30.984
23.854
Gross Profit/Loss - EUR
-4.667
47.591
5.931
6.052
7.615
4.485
20.839
1.241
-3.713
16.752
Net Profit/Loss - EUR
-5.025
44.776
5.245
5.347
6.921
4.179
20.071
604
-5.656
12.230
Employees
0
0
0
0
0
0
0
0
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 38.4%, from 26.538 euro in the year 2023, to 36.525 euro in 2024.
The Net Profit increased by 12.230 euro, from 0 euro in 2023, to 12.230 in the last year.
Check the financial reports for the company - Pharmas Srl
Financial Rating - PHARMAS SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Pharmas Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Pharmas Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Pharmas Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
50.422 euro in 2024 which includes Inventories of
0 euro, Receivables of
0 euro and cash availability of
50.422 euro.
The company's Equity was valued at
113.159 euro, while total Liabilities amounted to
1.360 euro.
Equity increased by 12.230 euro, from 101.496 euro in 2023, to 113.159 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Pharmas Srl